Unraveling the Heterogeneity of Hidradenitis Suppurativa with Schema

One of the major challenges faced with hidradenitis suppurativa (HS) is the variability in manifestations and treatment responses. Cazzaniga et al. (2020) conducted a cross-sectional study and latent class analysis to explain disease heterogeneity and formulate HS phenotypes. HS phenotypes might be useful for disease or treatment outcomes. Future studies should assess rater reliability and predictive validity for outcomes such as treatment response or disease progression.

Automated summary

Facing the challenge of hidradenitis suppurativa, understanding the variability in disease manifestations and treatment responses is crucial. Research suggests that formulating HS phenotypes can help guide treatment and predict outcomes. Future studies should focus on evaluating the reliability of the research and predictive validity.